Geneseeq
Geneseeq is a genomic testing company specializing in precision oncology, headquartered in Toronto and Nanjing, serving over 8,000 oncologists with a variety of genomic tests and supporting numerous translational research projects.
Geneseeq Services
Geneseeq offers genomic testing services for precision oncology, which include pan-cancer panels analyzing over 400 genes and cancer-type specific gene panels. The company provides high-quality genomic data using next-generation sequencing (NGS) with a fast turnaround to accelerate translational research. Geneseeq also offers a variety of genomic tests for different hematologic malignancies to aid in clinical diagnosis, treatment decision-making, and monitoring of minimal residual disease. The comprehensive genomic profiling covers all solid tumors and hematologic malignancies.
Geneseeq Founders and Headquarters
Founded in 2012, Geneseeq is headquartered in downtown Toronto, Canada, with additional headquarters located in Nanjing, China. The company employs over 30 passionate employees in Toronto and more than 1500 staff across China. The company's leadership and vision have established Geneseeq as a key player in the genomic testing and precision oncology sectors.
Geneseeq Products
Geneseeq's products include comprehensive genomic profiling tests for solid tumors and hematologic malignancies. The company's pan-cancer panels analyze over 400 genes, and there are specific gene panels tailored to different cancer types. These genomic tests are designed to aid in clinical diagnosis, treatment decision-making, and monitoring minimal residual disease in patients.
Geneseeq's Research Endeavors
Geneseeq has an impressive research portfolio, having published over 550 translational research papers in peer-reviewed journals. The company engages in over 2,000 translational research projects and supports over 60 biopharmaceutical companies in their clinical trials. Geneseeq's research services provide high-quality genomic data using next-generation sequencing, contributing significantly to the field of translational research.
Geneseeq's Sector and Reach
Operating within the field of genomic testing for precision oncology, Geneseeq caters to over 8,000 oncologists from more than 800 hospitals across 25 provinces in China. The company's products and services boast a testing capacity of over 250,000 samples per year. This widespread utilization highlights Geneseeq's significant impact and reach within the precision oncology sector.